Evidence map›Paper›PMID 28720108›Full record

ArticleBreast cancer research : BCR2017

Early pregnancy sex steroids during primiparous pregnancies and maternal breast cancer: a nested case-control study in the Northern Sweden Maternity Cohort.

Renée T Fortner, Eglé Tolockiene, Helena Schock, Husam Oda, Hans-Åke Lakso, Göran Hallmans, Rudolf Kaaks, Paolo Toniolo, Anne Zeleniuch-Jacquotte, Kjell Grankvist and 1 more

Open access · goldAbstract read
In one paragraph

Article in Breast cancer research : BCR, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.7field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Maternal Pregnancy Hormone Concentrations in Countries with Very Low and High Breast Cancer Risk.International journal of environmental research and public health · 2020
    Article
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 3 countries.

Renée T FortnerDivision of Cancer Epidemiology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, D-69120, Heidelberg, Germany. r.fortner@dkfz.de.
Eglé TolockieneDepartment of Medical Biosciences, Pathology, Umeå University, Umeå, Sweden.
Helena SchockDivision of Cancer Epidemiology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, D-69120, Heidelberg, Germany.
Husam OdaDepartment of Medical Biosciences, Pathology, Umeå University, Umeå, Sweden.
Hans-Åke LaksoDepartment of Medical Biosciences, Clinical Chemistry, Umeå University, Umeå, Sweden.
Göran HallmansPublic Health and Clinical Medicine: Nutritional Research, Umeå University, Umeå, Sweden.
Rudolf KaaksDivision of Cancer Epidemiology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, D-69120, Heidelberg, Germany.
Paolo TonioloDepartment of Obstetrics and Gynecology, New York University School of Medicine, New York, NY, USA.
Anne Zeleniuch-JacquotteDepartment of Population Health and Perlmutter Cancer Center, New York University School of Medicine, New York, NY, USA.
Kjell GrankvistDepartment of Medical Biosciences, Clinical Chemistry, Umeå University, Umeå, Sweden.
Eva LundinDepartment of Medical Biosciences, Pathology, Umeå University, Umeå, Sweden.
Umeå University · SEHeidelberg University · DENew York University · USGerman Cancer Research Center · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPregnancy and parity are associated with subsequent breast cancer risk. Experimental and epidemiologic data suggest a role for pregnancy sex steroid hormones.

methodsWe conducted a nested case-control study in the Northern Sweden Maternity Cohort (1975-2007). Eligible women had provided a blood sample in the first 20 weeks of gestation during a primiparous pregnancy leading to a term delivery. The current study includes 223 cases and 417 matched controls (matching factors: age at and date of blood collection). Estrogen receptor (ER) and progesterone receptor (PR) status was available for all cases; androgen receptor (AR) data were available for 41% of cases (n = 92). Sex steroids were quantified by high-performance liquid chromatography tandem mass spectrometry. Odds ratios (ORs) and 95% confidence intervals were estimated using conditional logistic regression.

resultsHigher concentrations of circulating progesterone in early pregnancy were inversely associated with ER+/PR+ breast cancer risk (OR

conclusionsConsistent with experimental models, high progesterone in early pregnancy was associated with lower risk of ER+/PR+ breast cancer in the mother. High circulating testosterone in early pregnancy, which likely reflects nonpregnant premenopausal exposure, was associated with higher risk of ER+/PR+ disease.

Indexed as

AdolescentAdultBiomarkersBreast NeoplasmsCase-Control StudiesFemaleGonadal Steroid HormonesHumansOdds RatioPregnancyReceptors, EstrogenReceptors, ProgesteroneSwedenYoung AdultBiomarkersGonadal Steroid HormonesReceptors, EstrogenReceptors, ProgesteroneBreast cancerEarly pregnancyEndogenous hormonesSex steroids

Identifiers

PMID28720108
PMCPMC5516370
OpenAlexW2738267732

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.